2025-01-01 2025-12-31 2025-12-31 true 13502785 AMO-06 PHARMA LIMITED 72110Research and experimental development on biotechnology iso4217:GBP xbrli:pure 135027852025-01-01 135027852025-12-31 135027852025-01-01 2025-12-31 13502785bus:Micro-entities2025-01-01 2025-12-31 13502785bus:AuditExempt-NoAccountantsReport2025-01-01 2025-12-31 13502785bus:FullAccounts2025-01-01 2025-12-31 13502785core:WithinOneYear2025-12-31 13502785core:AfterOneYear2025-12-31 13502785core:WithinOneYear2025-01-01 2025-12-31 13502785core:AfterOneYear2025-01-01 2025-12-31 13502785core:CurrentFinancialInstruments2025-12-31 13502785core:Non-currentFinancialInstruments2025-12-31 13502785core:CurrentFinancialInstruments2025-01-01 2025-12-31 13502785core:Non-currentFinancialInstruments2025-01-01 2025-12-31 13502785core:LandBuildings2025-01-01 2025-12-31 13502785core:FurnitureFittings2025-01-01 2025-12-31 13502785core:OfficeEquipment2025-01-01 2025-12-31 13502785core:Vehicles2025-01-01 2025-12-31 13502785core:PlantMachinery2025-01-01 2025-12-31 13502785core:OtherPropertyPlantEquipment2025-01-01 2025-12-31 13502785core:LandBuildings2025-12-31 13502785core:PlantMachinery2025-12-31 13502785core:Vehicles2025-12-31 13502785core:FurnitureFittings2025-12-31 13502785core:OfficeEquipment2025-12-31 13502785core:OtherPropertyPlantEquipment2025-12-31 13502785core:Right-of-useAssets2025-01-01 2025-12-31 13502785core:Right-of-useAssets2025-12-31 13502785core:Goodwill2025-01-01 2025-12-31 13502785core:PatentsTrademarksLicencesConcessionsSimilar2025-01-01 2025-12-31 13502785core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-01-01 2025-12-31 13502785core:OtherResidualIntangibleAssets2025-01-01 2025-12-31 13502785core:Goodwill2025-12-31 13502785core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-12-31 13502785core:PatentsTrademarksLicencesConcessionsSimilar2025-12-31 13502785core:OtherResidualIntangibleAssets2025-12-31 13502785dpl:CostSales2025-01-01 2025-12-31 13502785dpl:AdministrativeExpenses2025-01-01 2025-12-31 13502785dpl:DistributionCosts2025-01-01 2025-12-31135027852024-01-01 135027852024-12-31 135027852024-01-01 2024-12-31 13502785core:WithinOneYear2024-12-31 13502785core:AfterOneYear2024-12-31 13502785core:CurrentFinancialInstruments2024-12-31 13502785core:Non-currentFinancialInstruments2024-12-31 13502785core:LandBuildings2024-12-31 13502785core:PlantMachinery2024-12-31 13502785core:Vehicles2024-12-31 13502785core:FurnitureFittings2024-12-31 13502785core:OfficeEquipment2024-12-31 13502785core:OtherPropertyPlantEquipment2024-12-31 13502785core:Right-of-useAssets2024-12-31 13502785core:Goodwill2024-12-31 13502785core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-12-31 13502785core:PatentsTrademarksLicencesConcessionsSimilar2024-12-31 13502785core:OtherResidualIntangibleAssets2024-12-31 13502785dpl:AdministrativeExpenses2024-01-01 2024-12-3113502785bus:Director12025-01-01 2025-12-3113502785bus:PrivateLimitedCompanyLtd2025-01-01 2025-12-31
AMO-06 PHARMA LIMITED
Dormant Financial Statements
for the year ended 31 December 2025
Company registration number 13502785
(England and Wales)

Company Information

For the year ended 31 December 2025
Director Snape, Michael Frederick, Dr

Registered office Burnham House, Splash Lane
Wyton
Huntingdon
PE28 2AF

Registered number 13502785

Accountant Archangel Accounting Ltd
Burnham House
Splash Lane
Wyton
Huntingdon
Cambridgeshire
PE28 2AF

Statement of Financial Position

As at 31 December 2025
2025
2024
£
£
£
£
Current assets
(531)
(531)
Net current assets (liabilities)
(531)
(531)
Total assets less current liabilities
(531)
(531)
Net assets (liabilities)
(531)
(531)
Capital and reserves
(531)
(531)

Notes to the Financial Statements

1. Employees

The average number of employees during the year was 0 (2024: 0).
The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the Board of Directors on 8 May 2026 and are signed on its behalf by:

Snape, Michael Frederick, Dr
Snape, Michael Frederick, Dr
Director

Company registration number 13502785